Cerebral (company)
| Company type | Private |
|---|---|
| Industry | Telehealth, Mental health |
| Founded | 2020 |
| Founder | Kyle Robertson, Ho Anh |
| Headquarters | United States , United States |
Area served | Nationwide (United States) |
Key people | Brian Reinken (interim CEO), David Mou (former CEO), Kyle Robertson (founder) |
| Products | Virtual mental health solutions, therapy, counseling, medication oversight |
Cerebral Inc. is a U.S.-based telehealth provider delivering virtual mental health solutions, such as therapy, counseling, and medication oversight.
History
Established in 2020 by Kyle Robertson and Ho Anh, Cerebral swiftly grew its presence nationwide, assembling a network comprising thousands of licensed mental health professionals.[1] Early collaborations featured Olympic gold medalist Simone Biles serving as Chief Impact Officer.[2]
In June 2021, the company secured $127 million in funding at a valuation of $1.2 billion.[3] By December 2021, a $300 million Series C round led by SoftBank Vision Fund 2 elevated its valuation to approximately $4.8 billion.[4]
In 2022, Cerebral encountered regulatory examination concerning its prescribing practices for controlled medications such as Adderall, prompting an investigation by the U.S. Department of Justice (DOJ) under the Controlled Substances Act. Subsequently, the company ceased most prescriptions of controlled substances.[5]
After Kyle Robertson’s exit in mid-2022, Cerebral underwent staff reductions and adjusted its strategic direction amid ongoing regulatory and financial pressures.[6] David Mou, previously the chief medical officer, assumed the role of CEO. Robertson later launched Zealthy, another telemedicine venture.[7]
In November 2024, Cerebral agreed to a $3.65 million settlement to conclude the DOJ inquiry.[8] In December 2024, Mou resigned as CEO, with former board member Brian Reinken stepping in as interim chief executive.[9]
In August 2025, Cerebral completed the acquisition of Resilience Lab, a behavioral health organization focused on training clinicians early in their careers and mitigating burnout. This move is intended to broaden Resilience Lab’s training framework throughout Cerebral’s platform to improve care standards and outcomes for clients and insurers alike.[10]
Services
Cerebral provides digital mental health solutions such as counseling, psychiatric assessments, medication oversight, and continuous care. Utilizing a subscription model, the platform employs telemedicine tools to link clients with certified therapists and medical prescribers.
- ↑ "Cerebral in a new era with focus on clinical quality, CEO says". Fierce Healthcare. June 10, 2022.
- ↑ "Simone Biles Executes a Tricky New Move: Mental-Health Champion". WSJ.
- ↑ "Cerebral Raises $127 Million, Adds to Mental-Health Funding Surge". Wall Street Journal.
- ↑ "SoftBank Leads $300 Million Investment in Mental-Health Startup Cerebral". Wall Street Journal.
- ↑ "Mental-health startup Cerebral will stop prescribing most controlled drugs like Xanax and Adderall". Business Insider.
- ↑ "Cerebral cuts staff for 2nd time in 2022". Modern Healthcare.
- ↑ "Patients Are Choosing Zealthy—Here's Why It's a Healthcare Favourite". Fast Company.
- ↑ "Telehealth company Cerebral to pay $3.65 mln to resolve probe of Adderall sales". Reuters.
- ↑ "The former CEO of troubled startup Cerebral has a new project: another mental health company". Business Insider.
- ↑ "Cerebral Acquires Resilience Lab to Scale Proven Model of High Quality, Personalized Care". Yahoo Finance.